Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Gastroenterología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 4
ClinicalTrials.gov
An Open Label, Multicentre Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)
INTERVENTIONAL
Inicio: 1 de nov de 2007
ID: NCT00734097
Reclutando
Fase 3
ClinicalTrials.gov
A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Portal)
INTERVENTIONAL
Inicio: 20 de sept de 2018
ID: NCT03683251
Completado
Fase 1
ClinicalTrials.gov
A Randomized, Double-blind, Parallel Groups, Phase 1 Clinical Study Comparing the Pharmacokinetic, Safety and Immunogenicity of Adalimumab in Healthy Subjects
INTERVENTIONAL
Inicio: 1 de ago de 2022
ID: NCT06291948
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects With Ulcerative Colitis
INTERVENTIONAL
Inicio: 23 de feb de 2017
ID: NCT02914535
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Placebo Controlled, Dose-finding Study to Assess the Efficacy and Safety of SAR443122 in Adult Patients With Moderate to Severe Ulcerative Colitis
INTERVENTIONAL
Inicio: 25 de nov de 2022
ID: NCT05588843
Completado
Fase 2
ClinicalTrials.gov
A Phase l b/II a, Multicenter, Randomized, Double-Blinded, and Placebo-Controlled Study of the Antiviral Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C-Infection
INTERVENTIONAL
Inicio: 1 de abr de 2009
ID: NCT00911963
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
INTERVENTIONAL
Inicio: 23 de jul de 2019
ID: NCT03926130
Completado
ClinicalTrials.gov
Analysis of Brain Responses and Habituation to Multimodal Sensory Stimuli in Patients With Fibromyalgia
OBSERVATIONAL
Inicio: 14 de mar de 2025
ID: NCT06905171
Terminado
Fase 3
ClinicalTrials.gov
Satavaptan in the Prevention of Ascites Recurrence: a Double-blind, Randomised, Parallel-group Comparison of Satavaptan at 5 to 10 mg Daily Versus Placebo in the Absence of Diuretics in Patients With Recurrent Ascites Due to Cirrhosis of the Liver.
INTERVENTIONAL
Inicio: 1 de ago de 2006
ID: NCT00366795
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open-Label Study With Asunaprevir and Daclatasvir Plus Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) (P/R) (QUAD) for Subjects Who Are Null or Partial Responders to Peginterferon Alfa 2a or 2b Plus Ribavirin With Chronic Hepatitis C Genotypes 1 or 4 Infection
INTERVENTIONAL
Inicio: 1 de may de 2012
ID: NCT01573351
Aún no recluta
ClinicalTrials.gov
Development and Validation of an Obstetric Organ Dysfunction Score to Predict Mortality in Intensive Care Unit: A Multicenter, Prospective, Cohort Study
OBSERVATIONAL
Inicio: 1 de ago de 2025
ID: NCT07068022
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind Clinical Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy as First-line Treatment in Participants With HER2 Negative, Previously Untreated, Unresectable or Metastatic Gastric Orgastroesophageal Junction Adenocarcinoma (KEYNOTE-859)
INTERVENTIONAL
Inicio: 8 de nov de 2018
ID: NCT03675737
Reclutando
ClinicalTrials.gov
Music to Prevent Delirium: A Prospective, Randomized, Controlled, Three-Arm Parallel-Group Clinical Trial in an Argentine Intensive Care Unit
INTERVENTIONAL
Inicio: 2 de feb de 2026
ID: NCT07369258
Completado
Fase 2
ClinicalTrials.gov
A Phase 2a/2b Study of BMS-650032 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naive Subjects With Genotypes 1 and 4 Chronic Hepatitis C Infection
INTERVENTIONAL
Inicio: 1 de feb de 2010
ID: NCT01030432
Reclutando
ClinicalTrials.gov
Impact of Active Learning on Beliefs, Attitudes, Perceived Skills, and Application of Evidence-Based Practice in Undergraduate Physiotherapy Students
INTERVENTIONAL
Inicio: 31 de mar de 2025
ID: NCT06945367
Completado
Fase 4
ClinicalTrials.gov
An International, Multi-Center Study Evaluating the Correlation of IL28B Genotypes With Patient Demographics and Disease Characteristics in Patients With Chronic Hepatitis C
INTERVENTIONAL
Inicio: 1 de ago de 2011
ID: NCT01675427
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, With and Without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combination With Ribavirin, in the Treatment of Naïve Genotype 2 and 3 Chronic Hepatitis C Subjects
INTERVENTIONAL
Inicio: 1 de jul de 2012
ID: NCT01616524
Completado
ClinicalTrials.gov
Programme of Diabetes Education in the City of Corrientes (PRODIACOR): Clinical, Metabolic and Economic Outcomes of a Prospective-randomized Trial Based on Different Patient-centered Educational Strategies for People With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT01456806
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Multi-center, Phase 3 Study of Nivolumab in Combination With Ipilimumab Compared to Sorafenib or Lenvatinib as First-Line Treatment in Participants With Advanced Hepatocellular Carcinoma
INTERVENTIONAL
Inicio: 30 de sept de 2019
ID: NCT04039607
Completado
Fase 2
ClinicalTrials.gov
Study for the Prevention of Ascites (SPA): Comparison of Fixed Doses of SR121463B Versus Placebo in the Reduction of Recurrence of Cirrhotic Ascites
INTERVENTIONAL
Inicio: 1 de abr de 2004
ID: NCT00501384
Anterior
1
...
15
16
17
...
434
Siguiente
Filtros